GSK initiates phase III programme for novel type 2 diabetes medication, Syncria (albiglutide)

Links shared publicly online about this topic.

  • 2,250
    total visits

GSK initiates phase III programme for novel type 2 diabetes medication, Syncria (albiglutide)

gsk.com —

not named

View full resource at gsk.com

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Drug, GlaxoSmithKline

  • Share

Most Recently Shared on February 17, 2009 at 3:07 pm By:

eyeonfda eyeonfda

GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide) http://is.gd/jPfS

3 years ago...

Reply

Retweet

Favorite

Advertisement